What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the estimated listing price for Invicta Diagnostic Limited IPO?

Based on the upper price band of ₹85 and current GMP of ₹0, the estimated listing price is ₹85 (approx. 0.0% gain).

What is the expected profit per lot for Invicta Diagnostic Limited IPO?

With a lot size of 1600 shares and current GMP of ₹0, expected profit per retail application lot is approximately ₹0.

IPO GreyPremiumLIVE

Grey Market Intelligence

Invicta Diagnostic Limited

ListedSME

Healthcare · NSE

Incorporated in January 2021, Invicta Diagnostic Limited (operating as PC Diagnostics) is a Mumbai-based diagnostic services provider offering integrated radiology and pathology solutions through a hub-and-spoke model spread across the Mumbai Metropolitan Region, comprising a flagship advanced diagnostic hub in Thane West, three additional hubs in Bhayandar, Byculla, and Marol, and four spokes focused on basic imaging and sample collection; the company provides around 60 routine and 487 specialised pathology tests along with 96 basic and 130 advanced radiology tests, supported by a strong home-collection network and a team of 5 laboratory doctors, 20 radiologists, 127 technical staff, and 105 permanent employees as of May 31, 2025.

Price Band

₹80 – ₹85

Issue Size

₹28.12 Cr

Lot Size

1600 shares

GMP

—

Est. Listing

₹85

at current GMP

Subscribed

4.34x

overall

Open

1 Dec 2025

3 Dec 2025

Allotment

4 Dec 2025

Refund

5 Dec 2025

Demat Credit

6 Dec 2025

Listing

8 Dec 2025

Last updated 12 days ago

Overview Live GMP Live Subscription Allotment Status

Live Grey Market Premium

Invicta Diagnostic Limited GMP Today

Last updated: 19 Oct 2026

Current Premium

₹00.0%

Issue Price (Upper)

₹85

Band: ₹80 – ₹85

Estimated Listing Price

₹85

Upper price + GMP

Lot Size

1600 shares

Min investment ₹1,36,000

Estimated Profit / Lot

Date	GMP (₹)	GMP %	Est. Listing
31 Oct 2026	—	0.0%	₹85
30 Oct 2026	—	0.0%	₹85
29 Oct 2026	—	0.0%	₹85

About Invicta Diagnostic Limited Public Issue & Market Profile

Invicta Diagnostic Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹28.12 Crores. The shares are offered at a price band of ₹80 to ₹85 per equity share on NSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.

Public Issue & Pricing Context:

Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1600 shares (approx. ₹1,36,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.

Basis of Allotment & Listing Timeline:

Allotment reconciliation will be managed by Bigshare Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-12-06, while un-allotted funds or UPI block mandates will be released on 2025-12-05.

Frequently Asked Questions

What is Invicta Diagnostic Limited IPO GMP today?

The latest grey market premium for Invicta Diagnostic Limited IPO is ₹0, which indicates an expected listing price of ₹85.

What does Kostak Rate and Sauda mean in IPO GMP?

Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.

Is Grey Market Premium officially recognized?

No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.